{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T23:59:10Z","timestamp":1648857550948},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T00:00:00Z","timestamp":1416528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jphs.2014.11.004","type":"journal-article","created":{"date-parts":[[2014,11,22]],"date-time":"2014-11-22T15:50:38Z","timestamp":1416671438000},"page":"103-108","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Mechanism of action of hypoglycemic effects of an intestine-specific inhibitor of\u00a0microsomal triglyceride transfer protein (MTP) in obese rats"],"prefix":"10.1016","volume":"127","author":[{"given":"Shohei","family":"Sakata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohei","family":"Katsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuko","family":"Mera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiharu","family":"Kuroki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Nashida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Kakutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl.\u00a03","key":"10.1016\/j.jphs.2014.11.004_bib1","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.2337\/diabetes.53.suppl_3.S34","article-title":"Prevention of type 2 diabetes: insulin resistance and beta-cell function","volume":"53","author":"Chiasson","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.jphs.2014.11.004_bib2","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1007\/s00125-006-0316-2","article-title":"Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes","volume":"49","author":"Nathan","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.jphs.2014.11.004_bib3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrd2872","article-title":"Therapeutic targets to reduce cardiovascular disease in type 2 diabetes","volume":"8","author":"DeSouza","year":"2009","journal-title":"Nat Rev Drug Discov"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.jphs.2014.11.004_bib4","doi-asserted-by":"crossref","first-page":"S202","DOI":"10.2337\/dc11-s221","article-title":"Type 2 diabetes can be prevented with early pharmacological intervention","volume":"34","author":"DeFronzo","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jphs.2014.11.004_bib5","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1074\/jbc.M510622200","article-title":"Compensatory increase in hepatic lipogenesis in mice with conditional intestine-specific Mttp deficiency","volume":"281","author":"Xie","year":"2006","journal-title":"J\u00a0Biol Chem."},{"key":"10.1016\/j.jphs.2014.11.004_bib6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2261-5-30","article-title":"JTT-130, a microsomal triglyceride transfer protein (MTP) inhibitor lowers plasma triglycerides and LDL cholesterol concentrations without increasing hepatic triglycerides in guinea pigs","volume":"5","author":"Aggarwal","year":"2005","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jphs.2014.11.004_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1124\/jpet.110.173807","article-title":"Pharmacological characterization of diethyl-2-({3-dimethylcarbamoyl-4-[(4'-trifluoromethylbiphenyl-2-carbonyl)amino]p henyl}acetyloxymethyl)-2-phenylmalonate (JTT-130), an intestine-specific inhibitor of microsomal triglyceride transfer protein","volume":"336","author":"Mera","year":"2011","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jphs.2014.11.004_bib8","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1124\/jpet.110.176560","article-title":"JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses food intake and gastric emptying with the elevation of plasma peptide YY and glucagon-like peptide-1 in a dietary fat-dependent manner","volume":"336","author":"Hata","year":"2011","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jphs.2014.11.004_bib9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1463-1326.2011.01368.x","article-title":"JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses high fat diet-induced obesity and glucose intolerance in Sprague-Dawley rats","volume":"13","author":"Hata","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jphs.2014.11.004_bib10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1463-1326.2011.01387.x","article-title":"JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, ameliorates impaired glucose and lipid metabolism in Zucker diabetic fatty rats","volume":"13","author":"Hata","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jphs.2014.11.004_bib11","first-page":"803832","article-title":"JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, improves hyperglycemia and dyslipidemia independent of suppression of food intake in diabetic rats","volume":"2014","author":"Sakata","year":"2014","journal-title":"J\u00a0Diabetes Res"},{"key":"10.1016\/j.jphs.2014.11.004_bib12","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2337\/diab.36.8.914","article-title":"Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates","volume":"36","author":"Finegood","year":"1987","journal-title":"Diabetes"},{"key":"10.1016\/j.jphs.2014.11.004_bib13","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.2165\/00003495-200868150-00005","article-title":"New drugs for type 2 diabetes mellitus: what is their place in therapy?","volume":"68","author":"Krentz","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.jphs.2014.11.004_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/138945009787122860","article-title":"Emerging drug candidates of dipeptidyl peptidase IV (DPP IV) inhibitor class for the treatment of type 2 diabetes","volume":"10","author":"Gupta","year":"2009","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jphs.2014.11.004_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/MJT.0b013e3181afbf51","article-title":"Advances in the treatment of type 2 diabetes mellitus","volume":"18","author":"Israili","year":"2011","journal-title":"Am J Ther"},{"key":"10.1016\/j.jphs.2014.11.004_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2337\/dc08-1478","article-title":"Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels","volume":"32","author":"Utzschneider","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jphs.2014.11.004_bib17","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.2337\/dc10-0165","article-title":"Disposition index, glucose effectiveness, and conversion to type 2 diabetes: the Insulin Resistance Atherosclerosis Study (IRAS)","volume":"33","author":"Lorenzo","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jphs.2014.11.004_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11892-008-0032-z","article-title":"Ectopic fat and insulin resistance","volume":"8","author":"Lettner","year":"2008","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jphs.2014.11.004_bib19","first-page":"55","article-title":"Effects of beta glucan in highland barley on blood glucose and serum lipid in high fat-induced C57 mouse","volume":"47","author":"Tian","year":"2013","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"10.1016\/j.jphs.2014.11.004_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2152\/jmi.60.1","article-title":"Ectopic fat deposition and global cardiometabolic risk: new paradigm in cardiovascular medicine","volume":"60","author":"Shimabukuro","year":"2013","journal-title":"J\u00a0Med Invest"},{"key":"10.1016\/j.jphs.2014.11.004_bib21","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.3390\/nu5062019","article-title":"Body fat distribution and insulin resistance","volume":"5","author":"Patel","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.jphs.2014.11.004_bib22","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1172\/JCI200418917","article-title":"Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle","volume":"113","author":"Kim","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jphs.2014.11.004_bib23","doi-asserted-by":"crossref","first-page":"9597","DOI":"10.1073\/pnas.1409229111","article-title":"Role of diacylglycerol activation of PKC\u03b8 in lipid-induced muscle insulin resistance in humans","volume":"111","author":"Szendroedi","year":"2014","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861314000115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861314000115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T13:57:08Z","timestamp":1538056628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861314000115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1347861314000115"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2014.11.004","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of action of hypoglycemic effects of an intestine-specific inhibitor of\u00a0microsomal triglyceride transfer protein (MTP) in obese rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2014.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Japanese Pharmacological Society. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}